8-chloroadenosine-3',5'-cyclic monophosphorothioate has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies
Studies (8-chloroadenosine-3',5'-cyclic monophosphorothioate) | Trials (8-chloroadenosine-3',5'-cyclic monophosphorothioate) | Recent Studies (post-2010) (8-chloroadenosine-3',5'-cyclic monophosphorothioate) | Studies (1,3-dipropyl-8-cyclopentylxanthine) | Trials (1,3-dipropyl-8-cyclopentylxanthine) | Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine) |
---|---|---|---|---|---|
17 | 0 | 1 | 1,301 | 1 | 165 |
Protein | Taxonomy | 8-chloroadenosine-3',5'-cyclic monophosphorothioate (IC50) | 1,3-dipropyl-8-cyclopentylxanthine (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0051 | |
Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0038 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.2033 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.0234 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0083 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christie, MJ; Hack, SP; Vaughan, CW | 1 |
1 other study(ies) available for 8-chloroadenosine-3',5'-cyclic monophosphorothioate and 1,3-dipropyl-8-cyclopentylxanthine
Article | Year |
---|---|
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines | 2003 |